ACOR - Why Investors in Acorda Therapeutics #ACOR Consider Price Action to be a Tell
A tell is a precursor of a stock's next move, and #investors in Acorda Therapeutics (NASDAQ: ACOR) look for these #indicators all the time. the good news is, tells are there for investors to see every day. For example, we have provided this data for ACOR in the trading plans and summary table offered below. The tell is described there, for you to review. Our data was current at the time of publication, but it is not updated in real time here. If you want real time updates, or data on a different stock, please get one here Unlimited Real Time Reports .
Technical Summary
| Term ? | Near | Mid | Long |
|---|---|---|---|
| Bias | |||
| Weak | |||
| Strong | |||
| Strong | |||
| P1 | |||
| 0 | |||
| 0 | |||
| 4.10 | |||
| P2 | |||
| 4.10 | |||
| 4.39 | |||
| 5.57 | |||
| P3 | |||
| 4.41 | |||
| 4.98 | |||
| 7.24 |
Longer Term Trading Plans for ACOR
May 12, 2021, 8:30 am ET
Our Longer Term Plans for ACOR help you determine where to buy, sell, short, and set risk controls. Use this in conjunction with our Longer Term Market Analysis to go with the flow of the market as well. Going with the flow is extremely important, so review our Market Analysis and see how it helps you work with this ACOR Report.
ACOR - (Long) Support Plan
Buy over 4.10 target 5.57 stop loss @ 4.09
ACOR - (Short) Resistance Plan
Short under 5.57, target 4.10, stop loss @ 5.59